Market Research Industry Reports

Acasti Pharma Inc (ACST) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Acasti Pharma Inc (Acasti), a subsidiary of Neptune Technologies & Bioressources Inc is a biopharmaceutical company that offers research, development and commercialization of prescription drugs. The company offers products such as Onemia and CaPre. Its CaPre is developed for the prevention and treatment of cardiometabolic disorders including, hypertriglyceridemia. Acastis Onemia is an active ingredient used for clinical dietary management of cardiometabolic disorders. The companys products are used in the therapeutic areas of hyperlipidemia, atherosclerosis, diabetes, rheumatoid arthritis, and gastroenterology disorders. It conducts market research studies through collaborations with KOLs, high volume prescribers and pharmacies. Acasti is headquartered in Laval, Quebec, Canada.

Acasti Pharma Inc (ACST) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.




Acasti Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Acasti Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Acasti Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Acasti Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Acasti Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Acasti Pharma Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Acasti Pharma to Enter into Agreement with China-Based Pharmaceutical Company 10
Xymogen Enters Into Distribution Agreement With Acasti Pharm For LipiChol540 11
Equity Offering 12
Acasti Pharma Announces Exercise of Over-Allotment Option for Public Offering of Shares for USD0.7 Million 12
Acasti Pharma Raises USD4.35 Public Offering of Units 14
Acasti Pharma Raises USD4.3 Million in Public Offering of Units 16
Acasti Pharma Completes Private Placement Of Units For US$2 Million 18
Acasti Pharma Completes Public Offering Of Units For US$23 Million 19
Acasti Pharma Completes Private Placement Of Units For US$1 Million 21
Acasti Pharma Completes Private Placement Of Shares For US$1 Million 22
Debt Offering 23
Acasti Pharma Raises USD1.5 Million in Private Placement of 8% Debentures and Warrants Due 2020 23
Acasti Pharma Inc - Key Competitors 25
Acasti Pharma Inc - Key Employees 26
Acasti Pharma Inc - Locations And Subsidiaries 27
Head Office 27
Recent Developments 28
Financial Announcements 28
Feb 13, 2018: Acasti Pharma Reports Third Quarter FY 2018 Financial Results 28
Aug 14, 2017: Acasti Pharma Reports First Quarter FY 2018 Financial Results 30
Jun 06, 2017: Acasti Pharma Reports Fourth Quarter and Full-Year 2017 Financial Results 31
Jan 12, 2017: Acasti Pharma Reports Third Quarter 2017 Financial Results 33
Corporate Communications 34
Nov 16, 2017: Acasti Pharma Announces the Election of Its Directors 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List Of Tables

List of Tables
Acasti Pharma Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Acasti Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Acasti Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Acasti Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Acasti Pharma Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Acasti Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Acasti Pharma to Enter into Agreement with China-Based Pharmaceutical Company 10
Xymogen Enters Into Distribution Agreement With Acasti Pharm For LipiChol540 11
Acasti Pharma Announces Exercise of Over-Allotment Option for Public Offering of Shares for USD0.7 Million 12
Acasti Pharma Raises USD4.35 Public Offering of Units 14
Acasti Pharma Raises USD4.3 Million in Public Offering of Units 16
Acasti Pharma Completes Private Placement Of Units For US$2 Million 18
Acasti Pharma Completes Public Offering Of Units For US$23 Million 19
Acasti Pharma Completes Private Placement Of Units For US$1 Million 21
Acasti Pharma Completes Private Placement Of Shares For US$1 Million 22
Acasti Pharma Raises USD1.5 Million in Private Placement of 8% Debentures and Warrants Due 2020 23
Acasti Pharma Inc, Key Competitors 25
Acasti Pharma Inc, Key Employees 26

List Of Figures

List of Figures
Atlantic Power Corporation, Performance Chart (2013 - 2017) 27
Atlantic Power Corporation, Ratio Charts 29
Atlantic Power Corporation, Power, Deals By Year, 2012 to YTD 2018 30
Atlantic Power Corporation, Power, Deals by Type, 2012 to YTD 2018 31

International Datacasting Corporation Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

International Datacasting Corporation Company Profile is a detailed strategic and analytical report on International Datacasting Corporation. The 2018 version of the report offers detailed insights into the companys strategies, developments,

USD 200View Report

Acasti Pharma Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Acasti Pharma Inc Company Profile is a detailed strategic and analytical report on Acasti Pharma Inc. The 2018 version of the report offers detailed insights into the companys strategies, developments,

USD 200View Report

MEI Pharma Inc (MEIP) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

MEI Pharma Inc (MEI), formerly Marshall Edwards Inc is an oncology company that focuses on the development of drugs for the treatment of cancer. The companys drug candidates include pracinostat,

USD 250View Report

Antares Pharma Inc (ATRS) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Antares Pharma Inc (Antares Pharma) is a specialty pharmaceutical company that develops, manufactures, and commercializes self-administered parenteral pharmaceuticals and drug delivery systems and technologies. The companys portfolio encompasses novel

USD 250View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Apr 2018
No. of Pages :35
Country :Canada
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube